The Senate Committee on Commerce, Science, and Transportation held a nomination hearing for Michael Kratsios to serve as Director of the White House Office of Science and Technology Policy (OSTP). The questions and discussion centered on the committee’s technology agenda, with a strong emphasis on emerging fields such as artificial intelligence (AI) and quantum technology.
In his opening remarks, Chairman Ted Cruz (R-TX) argued that “the story of the twenty-first century will be written by whichever nation can innovate the fastest,” and thus technology is critical to American advancement on the world stage. He also emphasized the importance of technology in maintaining a strong U.S. economy.
Ranking Member Maria Cantwell (D-WA) highlighted that the bipartisan CHIPS and Science Act “recognizes American’s scientific enterprise [is] the foundation of the future.” Acknowledging that Kratsios would serve as the chief scientist guiding technological advancements in the U.S., she expressed her hope that he would strongly advocate for the committee’s desired investments in innovation. She also raised concern about the Trump administration’s plans to slash the funding of the National Science Foundation (NSF) by two-thirds and was eager to hear how Kratsios would address this budget challenge.
In his testimony, Kratsios emphasized his commitment to advancing science and technology if confirmed, citing his previous experience as Chief Technology Officer during the first Trump administration. He primarily focused on AI, quantum, nuclear, and other critical and emerging technologies throughout his remarks. He highlighted the American free-market approach to scientific discovery and its importance to innovation in academia.
Senator Lisa Blunt Rochester (D-DE) raised concerns about the mass firing of scientists and engineers at NIH. Kratsios responded that every new administration must assess its staff and determine the best way to advance the American people’s priorities. He felt the firings were a necessary and important step for a new administration.
Senator Tammy Baldwin (D-WI) asked whether reducing the NSF budget, and thus cutting research and development funding, would be wise. Kratsios noted that he cannot speak on the behalf of the NSF and as OSTP Director would follow what the president says is best. Senator Amy Klobuchar (D-MN) also wondered if he would commit to funding research and development at levels authorized by Congress. Kratsios again stated that he would work alongside President Trump.
On March 12, in a 24-4 vote, the committee advanced Kratsios’ nomination to the full Senate for final confirmation.
{Watch the Full Hearing Here} {Read Michael Kratsios’ Testimony Here}
